Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
If indeed there does need to be a public consultation then I can't see it holding the roll out much as the preparation can be undertaken concurrently. I cant see it also being a controversial consultation given the clear health and financial benefits to babies and the NHS.
Agree Roger65 - I think I remember a figure of c8m pa if AIHL was rolled out throughout the UK. What I dont know if specialist commissioning status was given, does that provide fund Trusts to purchase AIHL as a full NICE recommendation would (I think). Remember Mr Cheek said he was 100% sure specialist commissioning would happen and he was working very hard to make it happen sooner rather than later.
An exciting few days ahead esp if we get clarity on the FDA route and partners. Could we get to 20p with two stellar RNS's ?!?
Well done Roger....am sure you will be rewarded at these levels. Hopefully we will receive some good updates next week.
Impending positive good news will get it going!
Came across the below recently - expected publication date by March 2024:
https://shtg.scot/our-advice/clopidogrel-genotype-testing-after-ischaemic-stroke-or-transient-ischaemic-attack-tia/
Harrizma..yes the choice people have to make is who to believe. Roger65/Slacker and co or James Cheek. I know who I am listening to.
Roger65, correct me please if I am wrong but in the pre Christmas presentation, James Cheek was very clear that he needed addituonal funding for the FDA process and not 'to keep the lights on' as you so elegantly put it?
Nice 250k buy at the end of the day.
Good news for GDR.
Its an error
7.2p to buy now
Must be an error price is still c7p to buy/sell
The 147k is a buy but showing as a sell.
Confirmation!
I suspect conformation of specialist commissioning will come very soon....no CEX would say he is 100% sure it will happen unless he is indeed 100% sure it will happen.
There is always a transitionary period between a company developing a product and then commercialising it. We are in this period but very close to beginning the commercial roll out. Patience will be rewarded.
Guy, if you want to hear about the company's income then I suggest you listen to the CFO's presentation pre Christmas. You will also hear him say month outgoings are currently 327k when the R&D refund is factored in.
Hold firm, the promised good news is just around the corner.
Monthly spend is 327k when the R&D refund is factored in.
I contacted the NICE project team today for an update on timescales and whilst they obviously didnt give me much detail, the PM emailed to say that they would be updating stakeholders and the timelines 'soon'. This chimes with what Mr Cheek said in his pre Christmas update. Watch this space then....